# α-N-acetylgalactosaminidase Levels in Panic Disorder

> **NCT07424911** · — · COMPLETED · sponsor: **Elazığ Mental Health and Diseases Hospital** · enrollment: 66 (actual)

## Conditions studied

- Panic Disorder

## Interventions

- **OTHER:** No intervention was assigned as part of the research protocol. Participants with PD received routine clinical care.

## Key facts

- **NCT ID:** NCT07424911
- **Lead sponsor:** Elazığ Mental Health and Diseases Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-01
- **Primary completion:** 2025-06-16
- **Final completion:** 2025-08-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424911, "α-N-acetylgalactosaminidase Levels in Panic Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07424911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*